Annual CFO
$183.89 M
+$45.60 M+32.97%
December 31, 2024
Summary
- As of March 6, 2025, GDRX annual cash flow from operations is $183.89 million, with the most recent change of +$45.60 million (+32.97%) on December 31, 2024.
- During the last 3 years, GDRX annual CFO has risen by +$5.11 million (+2.86%).
- GDRX annual CFO is now at all-time high.
Performance
GDRX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$44.74 M
-$42.12 M-48.49%
December 31, 2024
Summary
- As of March 6, 2025, GDRX quarterly cash flow from operations is $44.74 million, with the most recent change of -$42.12 million (-48.49%) on December 31, 2024.
- Over the past year, GDRX quarterly CFO has dropped by -$42.12 million (-48.49%).
- GDRX quarterly CFO is now -48.49% below its all-time high of $86.86 million, reached on September 30, 2024.
Performance
GDRX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$183.89 M
+$28.88 M+18.63%
December 31, 2024
Summary
- As of March 6, 2025, GDRX TTM cash flow from operations is $183.89 million, with the most recent change of +$28.88 million (+18.63%) on December 31, 2024.
- Over the past year, GDRX TTM CFO has increased by +$28.88 million (+18.63%).
- GDRX TTM CFO is now at all-time high.
Performance
GDRX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
GDRX Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +33.0% | -48.5% | +18.6% |
3 y3 years | +2.9% | -25.8% | +19.2% |
5 y5 years | +120.8% | -25.8% | +19.2% |
GDRX Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +33.0% | -48.5% | +361.2% | at high | +43.9% |
5 y | 5-year | at high | +120.8% | -48.5% | +361.2% | at high | +303.3% |
alltime | all time | at high | +306.4% | -48.5% | +361.2% | at high | +303.3% |
GoodRx Holdings Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $183.89 M(+33.0%) | $44.74 M(-48.5%) | $183.89 M(+18.6%) |
Sep 2024 | - | $86.86 M(+795.4%) | $155.02 M(+20.7%) |
Jun 2024 | - | $9.70 M(-77.2%) | $128.43 M(-13.6%) |
Mar 2024 | - | $42.59 M(+168.4%) | $148.59 M(+7.4%) |
Dec 2023 | $138.29 M(-5.8%) | $15.87 M(-73.7%) | $138.29 M(-10.4%) |
Sep 2023 | - | $60.27 M(+101.8%) | $154.30 M(+20.8%) |
Jun 2023 | - | $29.87 M(-7.5%) | $127.77 M(-14.2%) |
Mar 2023 | - | $32.29 M(+1.3%) | $148.95 M(+1.5%) |
Dec 2022 | $146.78 M | $31.88 M(-5.5%) | $146.78 M(-10.9%) |
Sep 2022 | - | $33.73 M(-33.9%) | $164.71 M(-8.3%) |
Jun 2022 | - | $51.05 M(+69.5%) | $179.54 M(+9.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $30.12 M(-39.5%) | $163.41 M(-8.6%) |
Dec 2021 | $178.78 M(+36.1%) | $49.81 M(+2.6%) | $178.78 M(+24.3%) |
Sep 2021 | - | $48.56 M(+39.0%) | $143.82 M(+12.4%) |
Jun 2021 | - | $34.93 M(-23.2%) | $127.93 M(-2.5%) |
Mar 2021 | - | $45.48 M(+206.3%) | $131.23 M(-0.1%) |
Dec 2020 | $131.34 M(+57.7%) | $14.85 M(-54.5%) | $131.34 M(+12.7%) |
Sep 2020 | - | $32.67 M(-14.6%) | $116.49 M(+39.0%) |
Jun 2020 | - | $38.23 M(-16.1%) | $83.83 M(+83.9%) |
Mar 2020 | - | $45.59 M | $45.59 M |
Dec 2019 | $83.29 M(+84.0%) | - | - |
Dec 2018 | $45.25 M | - | - |
FAQ
- What is GoodRx Holdings annual cash flow from operations?
- What is the all time high annual CFO for GoodRx Holdings?
- What is GoodRx Holdings annual CFO year-on-year change?
- What is GoodRx Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for GoodRx Holdings?
- What is GoodRx Holdings quarterly CFO year-on-year change?
- What is GoodRx Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for GoodRx Holdings?
- What is GoodRx Holdings TTM CFO year-on-year change?
What is GoodRx Holdings annual cash flow from operations?
The current annual CFO of GDRX is $183.89 M
What is the all time high annual CFO for GoodRx Holdings?
GoodRx Holdings all-time high annual cash flow from operations is $183.89 M
What is GoodRx Holdings annual CFO year-on-year change?
Over the past year, GDRX annual cash flow from operations has changed by +$45.60 M (+32.97%)
What is GoodRx Holdings quarterly cash flow from operations?
The current quarterly CFO of GDRX is $44.74 M
What is the all time high quarterly CFO for GoodRx Holdings?
GoodRx Holdings all-time high quarterly cash flow from operations is $86.86 M
What is GoodRx Holdings quarterly CFO year-on-year change?
Over the past year, GDRX quarterly cash flow from operations has changed by -$42.12 M (-48.49%)
What is GoodRx Holdings TTM cash flow from operations?
The current TTM CFO of GDRX is $183.89 M
What is the all time high TTM CFO for GoodRx Holdings?
GoodRx Holdings all-time high TTM cash flow from operations is $183.89 M
What is GoodRx Holdings TTM CFO year-on-year change?
Over the past year, GDRX TTM cash flow from operations has changed by +$28.88 M (+18.63%)